Age-related macular degeneration (AMD) is a complex disorder with genetic and environmental influences. The genetic influences affecting AMD are not well understood and few genes have been consistently implicated and replicated for this disease. A polymorphism (rs11200638) in a transcription factor binding site of the HTRA1 gene has been described, in previous reports, as being most significantly associated with AMD. In this paper, we investigate haplotype association and individual polymorphic association by genotyping additional variants in the AMD risk-associated region of chromosome 10q26. We demonstrate that rs11200638 in the promoter region and rs2293870 in exon 1 of HTRA1, are among the most significantly associated variants for advanced forms of AMD.
Introduction
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the world. Advanced AMD results in central vision loss through two forms of the disease: geographic atrophy and choroidal neovascularization. Soft confluent drusen, which are small, yellowish, extracellular deposits of lipid, protein, and cellular debris are found in the macula and do not result in vision loss. Soft drusen are, however, significant risk factors for the two advanced forms of AMD.
AMD is a complex disease resulting from genetic and environmental influences. While this disease is known to have a genetic basis, few genes have been consistently implicated. The first major susceptibility gene for AMD, CFH, has been shown to be associated with geographic atrophy and choroidal neovascularization and has been replicated in multiple studies (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Li et al., 2006; Magnusson et al., 2006; Maller et al., 2006 ). An additional major locus at chromosome 10q26 has been shown in multiple independent studies to confer risk independent of the risk conferred by CFH Jakobsdottir et al., 2005; Maller et al., 2006; Rivera et al., 2005; Schmidt et al., 2006) . Recently a single nucleotide polymorphism (SNP) rs11200638 in a putative transcription factor binding site of the HTRA1 gene in the 10q26 region was shown to confer significant risk for choroidal neovascularization by our group and others (Dewan et al., 2006; Yang et al., 2006) . This association has been consistently replicated in AMD cohorts in Hong Kong Chinese, mainland Chinese, Utah European Americans, and Japanese populations (Lu et al., 2007; Mori et al., 2007; Yoshida et al., 2007) . The variant, rs11200638, has also been shown to confer susceptibility to both types of advanced AMD; geographic atrophy and choroidal neovascularization (Cameron et al., 2007) . In this paper, we investigate additional variants in chromosome 10q26. These variants span the genes previously reported as being most significantly associated with AMD (HTRA1, LOC387715, and PLEKHA1) in an expanded cohort, in which a subset has been previously shown to have association for the SNP rs11200638 in advanced AMD . We demonstrate that rs11200638 and the tri-allelic synonymous variant, rs2293870 are among the most significantly associated variants. We also demonstrate the haplotype structure and association patterns of 20 polymorphisms in the chromosome 10q region.
Methods

Patients
This study was approved by the Institutional Review Board of the University of Utah. All subjects provided informed consent prior to participation in the study. AMD patients were recruited in the Moran Eye Center at the University of Utah, as were normal age-matched controls, with eye examinations (individuals age 60 years or older with no drusen or RPE changes). All participants went through a standard examination protocol and visual acuity measurements. Slitlamp biomicroscopy of the fundi using a 90 diopter lens was performed. A stereoscopic color fundus photograph (50°) centered on the fovea was taken of each eye using a Topcon fundus camera (Topcon TRV-50VT, Topcon Optical Company, Tokyo, Japan) by trained ophthalmic photographers. Grading was carried out using a standard grid classification suggested by the International ARM Epidemiological Study Group for the age-related maculopathy (ARM) and age-related macular degeneration group (Bird et al., 1995) . All abnormalities in the macula were characterized according to type, size, and number of drusen, hyperpigmentation or hypopigmentation, and AMD stage.
The case cohort was comprised of European American individuals with an average age of 81.1 years and was 53.5% female. The control cohort was also European American individuals who had an average age of 75.3 years and was 61.2% male.
Genotyping
A Utah cohort of 342 advanced AMD patients, which included those with choroidal neovascularization and geographic atrophy, was genotyped and allele frequencies were compared to 215 age and ethnicity matched unaffected controls for all variants. Lab personnel were blinded to case/ control status. For SNP rs11200638, we PCR-amplified genomic DNA from AMD patients and age-matched controls using oligonucleotide primers 5 0 -ATGCCACCCACAACAACTTT-3 0 and 5 0 -CGCGTCCTTCA AACTAATGG-3 0 with 5% DMSO. The amplification parameters include denaturing at 95°C for 3 min, denaturing at 94°C for 30 s, annealing at 52°C for 30 s, extending at 72°C for 45 s for 35 cycles, and 72°C extension for an additional 10 min. The 385 bp PCR product was digested by restriction endonuclease Eag I, which generated 139 and 246 bp bands representing the normal G allele. An undigested PCR product represented the A allele. For rs10490924, forward primer 5 0 -TACCCAGGACCGATGG TAAC-3 0 and reverse primer 5 0 -GAGGAAGGCTGAATTGCCTA-3 0 were used for PCR amplification, PVUII digestion was used to identify the normal G allele as described previously . The remaining 18 10q26 polymorphisms were genotyped using the SNaP-SHOT method on an ABI 3130xl genetic analyzer (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. Additionally the rs11200638 polymorphism and the rs10490924 variant were regenotyped for all samples by the SNaPSHOT method in order to verify digestion results. All SNPs reported in this manuscript had a genotyping success rate >97% and accuracy >98% as judged by random re-genotyping of 10% of the samples.
Statistical analysis for 10q26.13
The chi-squared test for trend for an additive model over alleles was performed on each polymorphism to assess association with AMD. This statistical analysis utilized the ''Trend" program in the PEPI (Programs for EPIdemiologists) package. Linkage disequilibrium and haplotype analysis were examined in Haploview v3.32 using the default parameters.
Polymorphisms of note are deletion/insertion polymorphism (DIP) rs10664316 and SNP rs2293870. rs10664316 is a common variant comprised of the nucleotides AT or a 2 bp deletion. rs2293870 is a tri-allelic polymorphism (C/G/T). For the purposes of Fig. 1 and Haploview (which is limited to only bi-allelic polymorphisms), analysis was performed using G as the non-risk allele and C/T as the risk alleles.
All control cohort bi-allelic genotyping results were screened for deviations from Hardy-Weinberg equilibrium (p < 0.01) and SNPs with significant deviation were excluded.
Results
Genotyping and statistical results
We genotyped 19 SNPs and one DIP in the 10q26 region encompassing the genes PLEKHA1, LOC387715, and HTRA1 including one SNP, rs11200638, that has previously been reported as being significantly associated with advanced AMD in this cohort. Five SNPs and one DIP reside in the vicinity of LOC387715, eight SNPs are in or around HTRA1, and six SNPs are in or near PLELKHA1. Twelve variants throughout this region were significantly associated with advanced AMD after adjusting for multiple testing (p < 0.05/19 (2.6E À03), Table 1 ). This adjustment is conservative due to the correlation between the SNPs studied. SNP rs11200638 was the most significantly associated polymorphism with a chi-squared test for trend p-value equal to 1.26E À10 (Fig. 1) . The SNP with the next lowest p-value was rs2293870 in exon 1 of the HTRA1 gene, with a p-value of 4.78E À10 for advanced forms of AMD versus age and ethnicity matched controls. This variant is a synonymous SNP coding for the amino acid glycine. Therefore, the highest signals of association appear around or within the HTRA1 gene.
The third highest associated SNP was rs10490924 with a p-value of 6.18E À09. Fig. 1 and Table 1 shows the p-values from the chi-squared test for trend from all polymorphisms genotyped in the region for advanced AMD cases versus age and ethnicity matched controls.
Analysis of the LD structure demonstrates relatively lower LD between polymorphic markers in this region in the Utah population (Fig. 1B) than in a previously reported Hong Kong Chinese cohort. In particular, the D 0 -value was 0.75 between rs10490924 and rs11200638 in AMD cases from the Utah population (Fig. 1B) 
Discussion
To date, rs11200638, a promoter polymorphism in HTRA1, has been shown to be associated with choroidal neovascularization in five independent cohorts (Dewan et al., 2006; Lu et al., 2007; Mori et al., 2007; Yang et al., 2006; Yoshida et al., 2007) . Additionally, this polymorphism has been implicated as a risk variant in both Table  1 . From left to right the variants genotyped are: rs986960, rs1998345, rs2901307, rs4146894, rs2421016, rs1045216, rs10490924, rs3750848, rs3750847, rs3750846, rs10664316, rs2014307, rs3793917, rs11200638, rs2672598, rs1049331, rs2293870, rs4752700, rs2300431, rs714816 . Aligned below the Àlog(pvalues) graph is the linkage disequilibrium (LD) plot, generated in Haploview v3.32. The numbers listed in each square represent the D 0 -value for pair wise analysis. Similarly the color corresponds to the degree of linkage disequilibrium. The darker the square is, the higher the LD between the two polymorphisms being analyzed. The polymorphism positions were determined using the ''reference" assembly from the National Center for Biotechnology Information website.
forms of advanced AMD (Cameron et al., 2007) . To further examine this previously reported HTRA1 promoter SNP's association compared to other polymorphisms in the region, we genotyped a total of 20 tagging polymorphisms including this promoter SNP to survey their association with advanced AMD in an expanded Utah cohort.
From this comparative data, the HTRA1 promoter SNP, rs11200638, remains the most significantly associated with advanced AMD. In contrast, rs10490924 had the third lowest p-value with a p-value of 6.18E À09. Interestingly, the second most significant SNP, rs2293870, was located in exon 1 of the HTRA1 gene, further supporting an association of HTRA1 with AMD.
Beyond single SNP analysis, haplotype analysis, using Haploview v3.32 and the default parameters, demonstrates inferior haplotypes compared to similar single SNP analysis of rs11200638 and rs2293870 (Table 2 ). This suggests that the haplotype association can best be described by association from these SNPs.
Previous studies have suggested that the SNP rs10490924 in the gene LOC387715 is the most significantly associated variant and that LOC387715 is the second major susceptibility gene for age-related macular degeneration (Kanda et al., 2007; Rivera et al., 2005) . Our data in a Utah cohort argues strongly that HTRA1 is the most likely gene associated with AMD in the 10q region ( Fig. 1 and Table 1 ). In particular, we have identified an additional SNP variant, rs2293870, in HTRA1 that has a higher association signal than that of LOC387715 (rs10490924). Kanda et al. propose that LOC387715 encodes a mitochondrial protein, yet no protein expression data for LOC387715 have been described in the retina or RPE. This is in contrast to HTRA1 which has been shown to be expressed in drusen, a risk factor for advanced AMD (Cameron et al., 2007; Yang et al., 2006) .
The initial findings by Yang et al. and DeWan et al., as well as our current findings, demonstrate that rs11200638 and rs2293870 are the most significant variants within this region, particularly in light of the high amount of genotyping saturation presented. Both SNPs have more significant p-values than any of the SNPs genotyped in LOC387715.
On the basis of our statistical data, including haplotype analyses and association comparisons presented in this paper, rs11200638 in the promoter region of HTRA1 and Haplogroup association data for the most significantly associated haplotypes among the variants genotyped in the chromosome 10q region. No haplotype association p-values were lower than the p-value of rs11200638 and rs2293870 suggesting that the association in the region can best be explained by the association from these SNPs.
rs2293870 in exon 1 of HTRA1 are among the most significant variants in the 10q26 region presented thus far. These data, along with functional data presented to date, make the case for HTRA1 being the gene most likely associated with advanced AMD in the 10q region. The density of highly significant variants in HTRA1 supports this gene's involvement in advanced AMD thus highlighting the importance of future study on this gene and its function.
